Skip to main content
Frontiers in Cellular and Infection Microbiology logoLink to Frontiers in Cellular and Infection Microbiology
. 2026 Jun 19;16:1907033. doi: 10.3389/fcimb.2026.1907033

Correction: Metabolic dysfunction-associated steatotic liver disease in chronic hepatitis B patients: risks of severe liver disease and cardiovascular disease

Ningxin Zhang 1,†, Zhongwei Xu 1,†, Fei Lin 2, Haozhi Fan 3,4, Dehong Zhou 1, Shiqiu Zheng 1, Peng Jin 1, Huiquan Gu 1, Chengxiao Yu 2,5,*, Longfeng Jiang 1,*
PMCID: PMC13329340  PMID: 42404780

In the published article, there was a mistake in the Funding statement. The funding number for the Basic Research Program of Jiangsu was erroneously displayed as “SBK20250203138”. The correct statement is “Basic Research Program of Jiangsu (BK20251946)”.

The original version of this article has been updated.

Footnotes

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Cellular and Infection Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES